- Home
- OFS vs FBIO Comparison
OFS vs FBIO Comparison
Compare OFS & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFS
- FBIO
- Stock Information
- Founded
- OFS 2001
- FBIO 2006
- Country
- OFS United States
- FBIO United States
- Employees
- OFS N/A
- FBIO N/A
- Industry
- OFS Finance/Investors Services
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- OFS Finance
- FBIO Health Care
- Exchange
- OFS Nasdaq
- FBIO Nasdaq
- Market Cap
- OFS 95.6M
- FBIO 88.7M
- IPO Year
- OFS 2012
- FBIO N/A
- Fundamental
- Price
- OFS $5.00
- FBIO $2.60
- Analyst Decision
- OFS
- FBIO Strong Buy
- Analyst Count
- OFS 0
- FBIO 2
- Target Price
- OFS N/A
- FBIO $16.50
- AVG Volume (30 Days)
- OFS 115.3K
- FBIO 384.2K
- Earning Date
- OFS 10-30-2025
- FBIO 11-14-2025
- Dividend Yield
- OFS 13.60%
- FBIO N/A
- EPS Growth
- OFS N/A
- FBIO N/A
- EPS
- OFS 0.24
- FBIO N/A
- Revenue
- OFS $42,970,000.00
- FBIO $59,301,000.00
- Revenue This Year
- OFS N/A
- FBIO $31.85
- Revenue Next Year
- OFS N/A
- FBIO $44.43
- P/E Ratio
- OFS $20.74
- FBIO N/A
- Revenue Growth
- OFS N/A
- FBIO N/A
- 52 Week Low
- OFS $5.00
- FBIO $1.33
- 52 Week High
- OFS $9.80
- FBIO $4.20
- Technical
- Relative Strength Index (RSI)
- OFS 22.63
- FBIO 47.00
- Support Level
- OFS $5.07
- FBIO $2.40
- Resistance Level
- OFS $5.53
- FBIO $2.72
- Average True Range (ATR)
- OFS 0.38
- FBIO 0.13
- MACD
- OFS -0.05
- FBIO 0.03
- Stochastic Oscillator
- OFS 0.00
- FBIO 67.16
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.